1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cancer Molecular Biomarkers Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Genetic Methods 1.2.3 Protein Methods 1.2.4 Imaging 1.3 Market by Application 1.3.1 Global Cancer Molecular Biomarkers Market Share by Application: 2020 VS 2026 1.3.2 Pharmaceutical Companies 1.3.3 Medical Laboratory 1.3.4 Hospital 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cancer Molecular Biomarkers Market Perspective (2015-2026) 2.2 Global Cancer Molecular Biomarkers Growth Trends by Regions 2.2.1 Cancer Molecular Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Cancer Molecular Biomarkers Historic Market Share by Regions (2015-2020) 2.2.3 Cancer Molecular Biomarkers Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cancer Molecular Biomarkers Players by Market Size 3.1.1 Global Top Cancer Molecular Biomarkers Players by Revenue (2015-2020) 3.1.2 Global Cancer Molecular Biomarkers Revenue Market Share by Players (2015-2020) 3.2 Global Cancer Molecular Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cancer Molecular Biomarkers Revenue 3.4 Global Cancer Molecular Biomarkers Market Concentration Ratio 3.4.1 Global Cancer Molecular Biomarkers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cancer Molecular Biomarkers Revenue in 2019 3.5 Key Players Cancer Molecular Biomarkers Area Served 3.6 Key Players Cancer Molecular Biomarkers Product Solution and Service 3.7 Date of Enter into Cancer Molecular Biomarkers Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cancer Molecular Biomarkers Breakdown Data by Type (2015-2026) 4.1 Global Cancer Molecular Biomarkers Historic Market Size by Type (2015-2020) 4.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Type (2021-2026) 5 Cancer Molecular Biomarkers Breakdown Data by Application (2015-2026) 5.1 Global Cancer Molecular Biomarkers Historic Market Size by Application (2015-2020) 5.2 Global Cancer Molecular Biomarkers Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Cancer Molecular Biomarkers Market Size (2015-2026) 6.2 North America Cancer Molecular Biomarkers Market Size by Type (2015-2020) 6.3 North America Cancer Molecular Biomarkers Market Size by Application (2015-2020) 6.4 North America Cancer Molecular Biomarkers Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Cancer Molecular Biomarkers Market Size (2015-2026) 7.2 Europe Cancer Molecular Biomarkers Market Size by Type (2015-2020) 7.3 Europe Cancer Molecular Biomarkers Market Size by Application (2015-2020) 7.4 Europe Cancer Molecular Biomarkers Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Cancer Molecular Biomarkers Market Size (2015-2026) 8.2 China Cancer Molecular Biomarkers Market Size by Type (2015-2020) 8.3 China Cancer Molecular Biomarkers Market Size by Application (2015-2020) 8.4 China Cancer Molecular Biomarkers Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Cancer Molecular Biomarkers Market Size (2015-2026) 9.2 Japan Cancer Molecular Biomarkers Market Size by Type (2015-2020) 9.3 Japan Cancer Molecular Biomarkers Market Size by Application (2015-2020) 9.4 Japan Cancer Molecular Biomarkers Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Cancer Molecular Biomarkers Market Size (2015-2026) 10.2 Southeast Asia Cancer Molecular Biomarkers Market Size by Type (2015-2020) 10.3 Southeast Asia Cancer Molecular Biomarkers Market Size by Application (2015-2020) 10.4 Southeast Asia Cancer Molecular Biomarkers Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Correlogic Systems 11.1.1 Correlogic Systems Company Details 11.1.2 Correlogic Systems Business Overview 11.1.3 Correlogic Systems Cancer Molecular Biomarkers Introduction 11.1.4 Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2015-2020)) 11.1.5 Correlogic Systems Recent Development 11.2 AgendiaBv 11.2.1 AgendiaBv Company Details 11.2.2 AgendiaBv Business Overview 11.2.3 AgendiaBv Cancer Molecular Biomarkers Introduction 11.2.4 AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.2.5 AgendiaBv Recent Development 11.3 BioMerieux 11.3.1 BioMerieux Company Details 11.3.2 BioMerieux Business Overview 11.3.3 BioMerieux Cancer Molecular Biomarkers Introduction 11.3.4 BioMerieux Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.3.5 BioMerieux Recent Development 11.4 Aureon Laboratories 11.4.1 Aureon Laboratories Company Details 11.4.2 Aureon Laboratories Business Overview 11.4.3 Aureon Laboratories Cancer Molecular Biomarkers Introduction 11.4.4 Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.4.5 Aureon Laboratories Recent Development 11.5 Astellas Pharma US 11.5.1 Astellas Pharma US Company Details 11.5.2 Astellas Pharma US Business Overview 11.5.3 Astellas Pharma US Cancer Molecular Biomarkers Introduction 11.5.4 Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.5.5 Astellas Pharma US Recent Development 11.6 Becton 11.6.1 Becton Company Details 11.6.2 Becton Business Overview 11.6.3 Becton Cancer Molecular Biomarkers Introduction 11.6.4 Becton Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.6.5 Becton Recent Development 11.7 Diadexus 11.7.1 Diadexus Company Details 11.7.2 Diadexus Business Overview 11.7.3 Diadexus Cancer Molecular Biomarkers Introduction 11.7.4 Diadexus Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.7.5 Diadexus Recent Development 11.8 Abbott Laboratories 11.8.1 Abbott Laboratories Company Details 11.8.2 Abbott Laboratories Business Overview 11.8.3 Abbott Laboratories Cancer Molecular Biomarkers Introduction 11.8.4 Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.8.5 Abbott Laboratories Recent Development 11.9 Affymetrix 11.9.1 Affymetrix Company Details 11.9.2 Affymetrix Business Overview 11.9.3 Affymetrix Cancer Molecular Biomarkers Introduction 11.9.4 Affymetrix Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.9.5 Affymetrix Recent Development 11.10 Clarient 11.10.1 Clarient Company Details 11.10.2 Clarient Business Overview 11.10.3 Clarient Cancer Molecular Biomarkers Introduction 11.10.4 Clarient Revenue in Cancer Molecular Biomarkers Business (2015-2020) 11.10.5 Clarient Recent Development 11.11 Biomoda 10.11.1 Biomoda Company Details 10.11.2 Biomoda Business Overview 10.11.3 Biomoda Cancer Molecular Biomarkers Introduction 10.11.4 Biomoda Revenue in Cancer Molecular Biomarkers Business (2015-2020) 10.11.5 Biomoda Recent Development 11.12 Beckman Coulter 10.12.1 Beckman Coulter Company Details 10.12.2 Beckman Coulter Business Overview 10.12.3 Beckman Coulter Cancer Molecular Biomarkers Introduction 10.12.4 Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2015-2020) 10.12.5 Beckman Coulter Recent Development 11.13 Dickinson 10.13.1 Dickinson Company Details 10.13.2 Dickinson Business Overview 10.13.3 Dickinson Cancer Molecular Biomarkers Introduction 10.13.4 Dickinson Revenue in Cancer Molecular Biomarkers Business (2015-2020) 10.13.5 Dickinson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cancer Molecular Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Genetic Methods Table 4. Key Players of Protein Methods Table 5. Key Players of Imaging Table 6. Global Cancer Molecular Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 7. Global Cancer Molecular Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026 Table 8. Global Cancer Molecular Biomarkers Market Size by Regions (2015-2020) (US$ Million) Table 9. Global Cancer Molecular Biomarkers Market Share by Regions (2015-2020) Table 10. Global Cancer Molecular Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 11. Global Cancer Molecular Biomarkers Market Share by Regions (2021-2026) Table 12. Cancer Molecular Biomarkers Market Market Trends Table 13. Cancer Molecular Biomarkers Market Drivers Table 14. Cancer Molecular Biomarkers Market Challenges Table 15. Cancer Molecular Biomarkers Market Restraints Table 16. Global Cancer Molecular Biomarkers Revenue by Players (2015-2020) (US$ Million) Table 17. Global Cancer Molecular Biomarkers Market Share by Players (2015-2020) Table 18. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Molecular Biomarkers as of 2019) Table 19. Global Cancer Molecular Biomarkers by Players Market Concentration Ratio (CR5 and HHI) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Cancer Molecular Biomarkers Product Solution and Service Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Cancer Molecular Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 24. Global Cancer Molecular Biomarkers Market Size Share by Type (2015-2020) Table 25. Global Cancer Molecular Biomarkers Revenue Market Share by Type (2021-2026) Table 26. Global Cancer Molecular Biomarkers Market Size Share by Application (2015-2020) Table 27. Global Cancer Molecular Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 28. Global Cancer Molecular Biomarkers Market Size Share by Application (2021-2026) Table 29. North America Cancer Molecular Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 30. North America Cancer Molecular Biomarkers Market Share by Type (2015-2020) Table 31. North America Cancer Molecular Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 32. North America Cancer Molecular Biomarkers Market Share by Application (2015-2020) Table 33. North America Cancer Molecular Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 34. North America Cancer Molecular Biomarkers Market Share by Country (2015-2020) Table 35. Europe Cancer Molecular Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 36. Europe Cancer Molecular Biomarkers Market Share by Type (2015-2020) Table 37. Europe Cancer Molecular Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 38. Europe Cancer Molecular Biomarkers Market Share by Application (2015-2020) Table 39. Europe Cancer Molecular Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 40. Europe Cancer Molecular Biomarkers Market Share by Country (2015-2020) Table 41. China Cancer Molecular Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 42. China Cancer Molecular Biomarkers Market Share by Type (2015-2020) Table 43. China Cancer Molecular Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 44. China Cancer Molecular Biomarkers Market Share by Application (2015-2020) Table 45. China Cancer Molecular Biomarkers Market Size by Region (US$ Million) (2015-2020) Table 46. China Cancer Molecular Biomarkers Market Share by Region (2015-2020) Table 47. Japan Cancer Molecular Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 48. Japan Cancer Molecular Biomarkers Market Share by Type (2015-2020) Table 49. Japan Cancer Molecular Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 50. Japan Cancer Molecular Biomarkers Market Share by Application (2015-2020) Table 51. Japan Cancer Molecular Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 52. Japan Cancer Molecular Biomarkers Market Share by Country (2015-2020) Table 53. Southeast Asia Cancer Molecular Biomarkers Market Size by Type (2015-2020) (US$ Million) Table 54. Southeast Asia Cancer Molecular Biomarkers Market Share by Type (2015-2020) Table 55. Southeast Asia Cancer Molecular Biomarkers Market Size by Application (2015-2020) (US$ Million) Table 56. Southeast Asia Cancer Molecular Biomarkers Market Share by Application (2015-2020) Table 57. Southeast Asia Cancer Molecular Biomarkers Market Size by Country (US$ Million) (2015-2020) Table 58. Southeast Asia Cancer Molecular Biomarkers Market Share by Country (2015-2020) Table 59. Correlogic Systems Company Details Table 60. Correlogic Systems Business Overview Table 61. Correlogic Systems Product Table 62. Correlogic Systems Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 63. Correlogic Systems Recent Development Table 64. AgendiaBv Company Details Table 65. AgendiaBv Business Overview Table 66. AgendiaBv Product Table 67. AgendiaBv Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 68. AgendiaBv Recent Development Table 69. BioMerieux Company Details Table 70. BioMerieux Business Overview Table 71. BioMerieux Product Table 72. BioMerieux Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 73. BioMerieux Recent Development Table 74. Aureon Laboratories Company Details Table 75. Aureon Laboratories Business Overview Table 76. Aureon Laboratories Product Table 77. Aureon Laboratories Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 78. Aureon Laboratories Recent Development Table 79. Astellas Pharma US Company Details Table 80. Astellas Pharma US Business Overview Table 81. Astellas Pharma US Product Table 82. Astellas Pharma US Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 83. Astellas Pharma US Recent Development Table 84. Becton Company Details Table 85. Becton Business Overview Table 86. Becton Product Table 87. Becton Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 88. Becton Recent Development Table 89. Diadexus Company Details Table 90. Diadexus Business Overview Table 91. Diadexus Product Table 92. Diadexus Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 93. Diadexus Recent Development Table 94. Abbott Laboratories Business Overview Table 95. Abbott Laboratories Product Table 96. Abbott Laboratories Company Details Table 97. Abbott Laboratories Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 98. Abbott Laboratories Recent Development Table 99. Affymetrix Company Details Table 100. Affymetrix Business Overview Table 101. Affymetrix Product Table 102. Affymetrix Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 103. Affymetrix Recent Development Table 104. Clarient Company Details Table 105. Clarient Business Overview Table 106. Clarient Product Table 107. Clarient Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 108. Clarient Recent Development Table 109. Biomoda Company Details Table 110. Biomoda Business Overview Table 111. Biomoda Product Table 112. Biomoda Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 113. Biomoda Recent Development Table 114. Beckman Coulter Company Details Table 115. Beckman Coulter Business Overview Table 116. Beckman Coulter Product Table 117. Beckman Coulter Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 118. Beckman Coulter Recent Development Table 119. Dickinson Company Details Table 120. Dickinson Business Overview Table 121. Dickinson Product Table 122. Dickinson Revenue in Cancer Molecular Biomarkers Business (2015-2020) (US$ Million) Table 123. Dickinson Recent Development Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Molecular Biomarkers Market Share by Type: 2020 VS 2026 Figure 2. Genetic Methods Features Figure 3. Protein Methods Features Figure 4. Imaging Features Figure 5. Global Cancer Molecular Biomarkers Market Share by Application: 2020 VS 2026 Figure 6. Pharmaceutical Companies Case Studies Figure 7. Medical Laboratory Case Studies Figure 8. Hospital Case Studies Figure 9. Cancer Molecular Biomarkers Report Years Considered Figure 10. Global Cancer Molecular Biomarkers Market Size (US$ Million), YoY Growth 2015-2026 Figure 11. Global Cancer Molecular Biomarkers Market Share by Regions: 2020 VS 2026 Figure 12. Global Cancer Molecular Biomarkers Market Share by Regions (2021-2026) Figure 13. Global Cancer Molecular Biomarkers Market Share by Players in 2019 Figure 14. Global Top Cancer Molecular Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Molecular Biomarkers as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Cancer Molecular Biomarkers Revenue in 2019 Figure 16. North America Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. United States Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Canada Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Europe Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Asia-Pacific Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Latin America Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Middle East & Africa Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Cancer Molecular Biomarkers Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Correlogic Systems Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 44. AgendiaBv Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 45. BioMerieux Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 46. Aureon Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 47. Astellas Pharma US Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 48. Becton Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 49. Diadexus Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 50. Abbott Laboratories Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 51. Affymetrix Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 52. Clarient Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 53. Biomoda Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 54. Beckman Coulter Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 55. Dickinson Revenue Growth Rate in Cancer Molecular Biomarkers Business (2015-2020) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Correlogic Systems AgendiaBv BioMerieux Aureon Laboratories Astellas Pharma US Becton Diadexus Abbott Laboratories Affymetrix Clarient Biomoda Beckman Coulter Dickinson